Heath H. Galloway
Known title: EVP,General Counsel & CorpSecyCIK: 0001976274
Associated companies
Transaction History
| ACH | ▼ Sell | Tax Withholding | 1,822 | $5K | 5/18/2026 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 966 | $3K | 5/15/2026 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 9,347 | $19K | 3/20/2026 | View on chart |
| ACH | ▲ Buy | Grant | 61,437 | $0 | 3/9/2026 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,768 | $13K | 5/19/2025 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,315 | $9K | 5/15/2025 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 2,734 | $28K | 3/20/2025 | View on chart |
| ACH | ▲ Buy | Grant | 69,743 | $0 | 3/3/2025 | View on chart |
| ACH | ▼ Sell | Open Market | 2,052 | $39K | 5/17/2024 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,768 | $34K | 5/17/2024 | View on chart |
| ACH | ▼ Sell | Open Market | 2,031 | $41K | 5/16/2024 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,752 | $35K | 5/15/2024 | View on chart |
| ACH | ▲ Buy | Grant | 24,351 | $0 | 3/1/2024 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 107 | $2K | 2/7/2024 | View on chart |
| ACH | ▼ Sell | Open Market | 97 | $2K | 2/7/2024 | View on chart |
| ACH | ▲ Buy | Grant | 55 | $890 | 12/29/2023 | View on chart |
| ACH | ▼ Sell | Open Market | 5,500 | $97K | 11/10/2023 | View on chart |
| ACH | ▲ Buy | Grant | 56 | $909 | 6/30/2023 | View on chart |
| ACH | ▲ Buy | Grant | 17,794 | $0 | 5/17/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Accendra Health Receives NYSE Continued Listing Notice
Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.
Accendra Health Receives NYSE Continued Listing Notice. Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.